Boostrix-IPV is a medicine containing the active ingredient(s) diphtheria + tetanus + pertussis 3 component + polio trivalent vaccine. On this page you will find out more about Boostrix-IPV, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: diphtheria + tetanus + pertussis 3 component + polio trivalent vaccine
Information for medicine and pack size:
Boostrix-IPV injection suspension, 10 x 0.5 mL syringes
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
BOOSTRIX-IPV is indicated for booster vaccination against diphtheria, tetanus, pertussis and polio of individuals from the age of four years onwards.,The NHMRC currently recommends only 4 doses of polio vaccines in childhood and the polio boosters for adults are not necessary unless they are at special risk, such as: Travellers to areas or countries where poliomyelitis is epidemic or endemic; Health care workers in possible contact with poliomyelitis cases. For those exposed to continuing risk of infection a single booster dose is desirable every 10 years. The NHMRC currently recommends boosting against diphtheria, tetanus and pertussis using an adolescent/adult formulation dTpa at 15-17 years of age. Before the eighth birthday, DTP-containing vaccines should be given, as they contain a larger dose of diphtheria toxoid. After the eighth birthday, smaller doses of toxoid (adult/adolescent formulation dTpa or dt-containing vaccines) should be given.,A booster dose of dTpa is also recommended: Before planning pregnancy, or for both parents as soon as possible after delivery of an infant; For adults working with young children; For any adult expressing an interest in receiving a booster dose of dTpa, provided that a primary course of DTP vaccine has been given in the past.,Clinical data has demonstrated that in adults with an unknown history of pertussis vaccination, the majority had an immunogenic response to pertussis when given BOOSTRIX-IPV (see PHARMACOLOGY).,Finally all adults reach the age of 50 years without having received a boosting dose of dT in the previous 5 years should receive a further boosting dose of dT, where the adult/adolescent formulation dTpa can be used instead.,BOOSTRIX-IPV is not intended for primary immunisation.
Table of characteristics
|Visual appearance||Turbid liquid, white deposit, colourless supernatant|
|Dosage Form||Injection, suspension|
|Route of administration||Intramuscular|
Pack of 1 pre-filled syringe: Prescription Only Medicine, or Prescription Animal Remedy
Pack of 10 pre-filled syringe: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store at 2 to 8 degrees Celsius|
|Storage conditions||Do not Freeze|
|Life time||3 Years|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.